{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:13:21Z","timestamp":1791972801014,"version":"4.3.4"},"reference-count":145,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Currently, there is no reliable method of discerning between low-risk and high-risk intraductal papillary mucinous neoplasms (IPMNs). Operative resection is utilized in an effort to resect those lesions with high-grade dysplasia (HGD) prior to the development of invasive disease. The current guidelines recommend resection for IPMN that involve the main pancreatic duct. Resecting lesions with HGD before their progression to invasive disease and the avoidance of resection in those patients with low-grade dysplasia is the optimal clinical scenario. Therefore, the importance of developing preoperative models able to discern HGD in IPMN patients cannot be overstated. Low-risk patients should be managed with nonsurgical treatment options (typically MRI surveillance), while high-risk patients would undergo resection, hopefully prior to the formation of invasive disease. Current research is evolving in multiple directions. First, there is an ongoing effort to identify reliable markers for predicting malignant transformation of IPMN, mainly focusing on genomic and transcriptomic data from blood, tissue, and cystic fluid. Also, multimodal models of combining biomarkers with clinical and radiographic data seem promising for providing robust and accurate answers of risk levels for IPMN patients.<\/jats:p>","DOI":"10.3390\/cancers16223825","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:06:32Z","timestamp":1731571592000},"page":"3825","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["An Overview for Clinicians on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5276-0699","authenticated-orcid":false,"given":"Dimitrios","family":"Moris","sequence":"first","affiliation":[{"name":"MedStar Georgetown Transplant Institute, Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6240-4228","authenticated-orcid":false,"given":"Ioannis","family":"Liapis","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Gupta","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6742-6909","authenticated-orcid":false,"given":"Ioannis A.","family":"Ziogas","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Colorado School of Medicine, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia-Sofia","family":"Karachaliou","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-3712","authenticated-orcid":false,"given":"Nikolaos","family":"Dimitrokallis","sequence":"additional","affiliation":[{"name":"1st Department of Surgery & Organ Transplant Unit, Evangelismos General Hospital, 10676 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Nguyen","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Radkani","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100278","DOI":"10.1016\/j.ejro.2020.100278","article-title":"Differentiating Benign from Malignant Pancreatic Cysts on Computed Tomography","volume":"7","author":"Yadav","year":"2020","journal-title":"Eur. J. Radiol. Open"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e2338696","DOI":"10.1001\/jamanetworkopen.2023.38696","article-title":"IPMNs of the Pancreas: More Epidemiologically Than Clinically Relevant","volume":"6","author":"Crippa","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.soc.2015.11.002","article-title":"Spectrum and Classification of Cystic Neoplasms of the Pancreas","volume":"25","author":"Greer","year":"2016","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/00365521.2017.1318948","article-title":"Intraductal Papillary Mucinous Neoplasm of the Pancreas\u2014Epidemiology, Risk Factors, Diagnosis, and Management","volume":"52","author":"Aronsson","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/00006676-200304000-00023","article-title":"Intraductal Papillary Mucinous Neoplasm: Did It Exist Prior to 1980?","volume":"26","author":"Tollefson","year":"2003","journal-title":"Pancreas"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrgastro.2012.31","article-title":"Intraductal Papillary Mucinous Neoplasms of the Pancreas\u2013a Surgical Disease","volume":"9","author":"Werner","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kl\u00f6ppel, G., Solcia, E., Sobin, L.H., Longnecker, D.S., and Capella, C. (1996). Histological Typing of Tumours of the Exocrine Pancreas, Springer.","DOI":"10.1007\/978-3-642-61024-0"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00000658-199602000-00005","article-title":"Mucin-Producing Neoplasms of the Pancreas. Intraductal Papillary and Mucinous Cystic Neoplasms","volume":"223","author":"Papillary","year":"1996","journal-title":"Ann. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cgh.2015.08.038","article-title":"Association Between Advances in High-Resolution Cross-Section Imaging Technologies and Increase in Prevalence of Pancreatic Cysts from 2005 to 2014","volume":"14","author":"Moris","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.sla.0000128306.90650.aa","article-title":"Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Updated Experience","volume":"239","author":"Sohn","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1200\/JCO.19.03141","article-title":"Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology","volume":"38","author":"Markham","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yao.2023.12.003","article-title":"Current Management of Intraductal Papillary Mucinous Neoplasms","volume":"4","author":"Pollini","year":"2024","journal-title":"Adv. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","article-title":"International Evidence-Based Kyoto Guidelines for the Management of Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"24","author":"Ohtsuka","year":"2024","journal-title":"Pancreatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","article-title":"Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-Term Surveillance","volume":"155","author":"Canto","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MPA.0000000000001001","article-title":"The 2012 International Consensus Guidelines of Intraductal Papillary Mucinous Neoplasms of the Pancreas (Fukuoka Criteria) Predict the Malignant Potential, Even in Actual Clinical Situations","volume":"47","author":"Okamura","year":"2018","journal-title":"Pancreas"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4251\/wjgo.v6.i9.311","article-title":"Pathological Features and Diagnosis of Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"6","year":"2014","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3748\/wjg.15.628","article-title":"Multifocal Intraductal Papillary Mucinous Neoplasm of the Pancreas\u2014A Case Report","volume":"15","author":"Chiang","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.4251\/wjgo.v13.i12.1880","article-title":"Pancreatic Intraductal Papillary Mucinous Neoplasms: Current Diagnosis and Management","volume":"13","author":"Szmigiel","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.25259\/JCIS_15_2020","article-title":"Role of Cross-Sectional Imaging (CT\/MRI) in Characterization and Distinguishing Benign from Malignant\/Potentially Malignant Cystic Lesions of Pancreas","volume":"10","author":"Abraham","year":"2020","journal-title":"J. Clin. Imaging Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/den.13626","article-title":"Diagnostic Performance of Endoscopic Ultrasound Through-the-Needle Microforceps Biopsy of Pancreatic Cystic Lesions: Systematic Review with Meta-Analysis","volume":"32","author":"Tacelli","year":"2020","journal-title":"Dig. Endosc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1148\/radiol.2019190144","article-title":"Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines","volume":"293","author":"Lee","year":"2019","journal-title":"Radiology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pan.2023.12.002","article-title":"Association of High-Risk Stigmata and Worrisome Features with Advanced Neoplasia in Intraductal Papillary Mucinous Neoplasms (IPMN): A Systematic Review","volume":"24","author":"Ohno","year":"2024","journal-title":"Pancreatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/SLA.0b013e3182444231","article-title":"The Carcinoembryonic Antigen Level in Pancreatic Juice and Mural Nodule Size Are Predictors of Malignancy for Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"255","author":"Hirono","year":"2012","journal-title":"Ann. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.bpg.2016.10.013","article-title":"Surveillance for Neoplasia in the Pancreas","volume":"30","author":"Overbeek","year":"2016","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.14309\/ajg.0000000000000378","article-title":"\u201cTrivial\u201d Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?","volume":"114","author":"Marchegiani","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.gastro.2019.08.032","article-title":"Long-Term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms","volume":"158","author":"Oyama","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1038\/s41424-018-0026-3","article-title":"Long-Term Follow-up of Low-Risk Branchduct IPMNs of the Pancreas: Is Main Pancreatic Duct Dilatation the Most Worrisome Feature?","volume":"9","author":"Petrone","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MPA.0000000000001027","article-title":"Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance Cohort","volume":"47","author":"Gausman","year":"2018","journal-title":"Pancreas"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0b013e31819a6e16","article-title":"Global Genomic Analysis of Intraductal Papillary Mucinous Neoplasms of the Pancreas Reveals Significant Molecular Differences Compared to Ductal Adenocarcinoma","volume":"249","author":"Fritz","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jamcollsurg.2014.11.029","article-title":"GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma","volume":"220","author":"Tan","year":"2015","journal-title":"J. Am. Coll. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00534-009-0105-7","article-title":"Increased K-Ras Mutation and Expression of S100A4 and MUC2 Protein in the Malignant Intraductal Papillary Mucinous Tumor of the Pancreas","volume":"16","author":"Jang","year":"2009","journal-title":"J. Hepatobiliary Pancreat. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00423-008-0285-7","article-title":"PIK3CA, KRAS, and BRAF Mutations in Intraductal Papillary Mucinous Neoplasm\/Carcinoma (IPMN\/C) of the Pancreas","volume":"393","author":"Qiu","year":"2008","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.suc.2016.07.014","article-title":"Genetics of Pancreatic Cancer and Its Implications on Therapy","volume":"96","author":"Tatarian","year":"2016","journal-title":"Surg. Clin. N. Am."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1440-1746.2005.03958.x","article-title":"Clinicopathological Features and Medical Management of Intraductal Papillary Mucinous Neoplasms","volume":"21","author":"Okabayashi","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.pan.2023.08.002","article-title":"Systematic Review of Challenging Issues in Pathology of Intraductal Papillary Mucinous Neoplasms","volume":"23","author":"Wood","year":"2023","journal-title":"Pancreatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/br.2014.376","article-title":"Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 for Prediction of Malignancy and Invasiveness in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Meta-Analysis","volume":"3","author":"Wang","year":"2015","journal-title":"Biomed. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/bjs.7280","article-title":"Role of Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Distinguishing between Benign and Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"98","author":"Fritz","year":"2011","journal-title":"Br. J. Surg."},{"key":"ref_38","first-page":"8061","article-title":"Intraductal Papillary Mucinous Neoplasms of the Pancreas: Clinical Association with KRAS","volume":"17","author":"Chang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPA.0000000000000253","article-title":"Molecular Biomarkers for Progression of Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"44","author":"Kuboki","year":"2015","journal-title":"Pancreas"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1245\/s10434-013-3096-1","article-title":"Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas","volume":"20","author":"Matthaei","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"92ra66","DOI":"10.1126\/scitranslmed.3002543","article-title":"Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development","volume":"3","author":"Wu","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Mas, L., Lupinacci, R.M., Cros, J., Bachet, J.-B., Coulet, F., and Svrcek, M. (2021). Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136756"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MPA.0000000000000258","article-title":"Clinical Significance of GNAS Mutation in Intraductal Papillary Mucinous Neoplasm of the Pancreas with Concomitant Pancreatic Ductal Adenocarcinoma","volume":"44","author":"Ideno","year":"2015","journal-title":"Pancreas"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/onc.2015.294","article-title":"GNAS(R201H) and Kras(G12D) Cooperate to Promote Murine Pancreatic Tumorigenesis Recapitulating Human Intraductal Papillary Mucinous Neoplasm","volume":"35","author":"Taki","year":"2016","journal-title":"Oncogene"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1245\/s10434-019-07389-6","article-title":"GNAS but Not Extended RAS Mutations Spectrum Are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms","volume":"26","author":"Gaujoux","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2019.06.001","article-title":"Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations","volume":"157","author":"Fischer","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1007\/s00330-020-07583-1","article-title":"Intraductal Papillary Mucinous Neoplasm of the Pancreas: Diagnostic Performance of the 2017 International Consensus Guidelines Using CT and MRI","volume":"31","author":"Min","year":"2021","journal-title":"Eur. Radiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0039-6060(97)90136-7","article-title":"Two Types of Mucin-Producing Cystic Tumors of the Pancreas: Diagnosis and Treatment","volume":"122","author":"Sugiyama","year":"1997","journal-title":"Surgery"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2214\/ajr.174.5.1741403","article-title":"MR Cholangiopancreatographic Differentiation of Benign and Malignant Intraductal Mucin-Producing Tumors of the Pancreas","volume":"174","author":"Irie","year":"2000","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2214\/AJR.12.9511","article-title":"Intraductal Papillary Mucinous Neoplasms with Associated Invasive Carcinoma of the Pancreas: Imaging Findings and Diagnostic Performance of MDCT for Prediction of Prognostic Factors","volume":"201","author":"Kim","year":"2013","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/1751-2980.12801","article-title":"Pancreatic Fat Content May Increase the Risk of Imaging Progression in Low-Risk Branch Duct Intraductal Papillary Mucinous Neoplasm","volume":"20","author":"Kashiwagi","year":"2019","journal-title":"J. Dig. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhang, T.T., Sadler, T.J., Whitley, S., Brais, R., and Godfrey, E. (2019). The CT Fish Mouth Ampulla Sign: A Highly Specific Finding in Main Duct and Mixed Intraductal Papillary Mucinous Neoplasms. Br. J. Radiol., 92.","DOI":"10.1259\/bjr.20190461"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.eururo.2020.04.064","article-title":"Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients","volume":"78","author":"Abrishami","year":"2020","journal-title":"Eur. Urol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/SLA.0b013e31829385f7","article-title":"Imaging Features to Distinguish Malignant and Benign Branch-Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Meta-Analysis","volume":"259","author":"Kim","year":"2014","journal-title":"Ann. Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/SLA.0b013e3181a189a8","article-title":"Intraductal Papillary Mucinous Neoplasms of the Pancreas: Differentiation of Malignant and Benign Tumors by Endoscopic Ultrasound Findings of Mural Nodules","volume":"249","author":"Ohno","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cgh.2006.12.007","article-title":"Role of Endoscopic Ultrasound in the Diagnosis of Intraductal Papillary Mucinous Neoplasms: Correlation with Surgical Histopathology","volume":"5","author":"Pais","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pan.2011.12.008","article-title":"Endoscopic Ultrasonographic Findings Predict the Risk of Carcinoma in Branch Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"12","author":"Kobayashi","year":"2012","journal-title":"Pancreatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.surg.2018.01.009","article-title":"Systematic Review, Meta-Analysis, and a High-Volume Center Experience Supporting the New Role of Mural Nodules Proposed by the Updated 2017 International Guidelines on IPMN of the Pancreas","volume":"163","author":"Marchegiani","year":"2018","journal-title":"Surgery"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.gie.2016.02.008","article-title":"Management of Branch-Duct Intraductal Papillary Mucinous Neoplasms: A Large Single-Center Study to Assess Predictors of Malignancy and Long-Term Outcomes","volume":"84","author":"Ridtitid","year":"2016","journal-title":"Gastrointest. Endosc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/den.13408","article-title":"Usefulness of Septal Thickness Measurement on Endoscopic Ultrasound as a Predictor of Malignancy of Branched-Duct and Mixed-Type Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"31","author":"Iwaya","year":"2019","journal-title":"Dig. Endosc."},{"key":"ref_61","first-page":"409","article-title":"Cyst Fluid Carcinoembryonic Antigen Level Is Not Predictive of Invasive Cancer in Patients with Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"13","author":"Kucera","year":"2012","journal-title":"JOP"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1111\/j.1572-0241.2008.02114.x","article-title":"Intraductal Papillary Mucinous Neoplasms of the Pancreas: Performance of Pancreatic Fluid Analysis for Positive Diagnosis and the Prediction of Malignancy","volume":"103","author":"Maire","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5946\/ce.2020.083","article-title":"Cyst Fluid Carcinoembryonic Antigen Level Difference between Mucinous Cystic Neoplasms and Intraductal Papillary Mucinous Neoplasms","volume":"54","author":"Malya","year":"2021","journal-title":"Clin. Endosc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000134276","article-title":"Cytological and Cyst Fluid Analysis of Small (\u22643 cm) Branch Duct Intraductal Papillary Mucinous Neoplasms Adds Value to Patient Management Decisions","volume":"8","author":"Pitman","year":"2008","journal-title":"Pancreatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00535-019-01592-8","article-title":"Carcinoembryonic Antigen Level in the Pancreatic Juice Is Effective in Malignancy Diagnosis and Prediction of Future Malignant Transformation of Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"54","author":"Hayakawa","year":"2019","journal-title":"J. Gastroenterol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.pan.2019.02.013","article-title":"Evaluation of Efficacy of Pancreatic Juice Cytology for Risk Classification According to International Consensus Guidelines in Patients with Intraductal Papillary Mucinous Neoplasm; a Retrospective Study","volume":"19","author":"Yamakawa","year":"2019","journal-title":"Pancreatology"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Turner, R.C., Melnychuk, J.T., Chen, W., Jones, D., and Krishna, S.G. (2022). Molecular Analysis of Pancreatic Cyst Fluid for the Management of Intraductal Papillary Mucinous Neoplasms. Diagnostics, 12.","DOI":"10.3390\/diagnostics12112573"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/dc.20085","article-title":"Cyst Fluid Analysis for the Differential Diagnosis of Pancreatic Cysts","volume":"31","author":"Ryu","year":"2004","journal-title":"Diagn. Cytopathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5107(05)01581-6","article-title":"Cyst Fluid Analysis in the Differential Diagnosis of Pancreatic Cystic Lesions: A Pooled Analysis","volume":"62","author":"Porte","year":"2005","journal-title":"Gastrointest. Endosc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrgastro.2013.120","article-title":"Mucins in Pancreatic Cancer and Its Microenvironment","volume":"10","author":"Kaur","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/jcp.2003.013292","article-title":"MUC1 and MUC2 in Pancreatic Neoplasia: Figure 1","volume":"57","author":"Levi","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/MPA.0b013e3182580fb4","article-title":"Genetic Markers of Malignant Transformation in Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Meta-Analysis","volume":"41","author":"Nissim","year":"2012","journal-title":"Pancreas"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00000478-200407000-00001","article-title":"Pathologically and Biologically Distinct Types of Epithelium in Intraductal Papillary Mucinous Neoplasms: Delineation of an \u201cIntestinal\u201d Pathway of Carcinogenesis in the Pancreas","volume":"28","author":"Adsay","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.mpa.0000202939.40213.fd","article-title":"High Expression of Intestinal-Type Mucin (MUC2) in Intraductal Papillary Mucinous Neoplasms Coexisting With Extrapancreatic Gastrointestinal Cancers","volume":"32","author":"Lee","year":"2006","journal-title":"Pancreas"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1245\/s10434-010-1225-7","article-title":"Pancreatic Cyst Fluid and Serum Mucin Levels Predict Dysplasia in Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"18","author":"Maker","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1136\/gutjnl-2013-306219","article-title":"MAb Das-1 Is Specific for High-Risk and Malignant Intraductal Papillary Mucinous Neoplasm (IPMN)","volume":"63","author":"Das","year":"2014","journal-title":"Gut"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.gastro.2019.05.014","article-title":"Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions","volume":"157","author":"Das","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jamcollsurg.2017.07.521","article-title":"Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia","volume":"225","author":"Carr","year":"2017","journal-title":"J. Am. Coll. Surg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1158\/1078-0432.CCR-10-1561","article-title":"Cyst Fluid Interleukin-1beta (IL1beta) Levels Predict the Risk of Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"17","author":"Maker","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/MPA.0000000000001377","article-title":"Pancreatic Fluid Interleukin-1\u03b2 Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia","volume":"48","author":"Simpson","year":"2019","journal-title":"Pancreas"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"21188","DOI":"10.1073\/pnas.1118046108","article-title":"Whole-Exome Sequencing of Neoplastic Cysts of the Pancreas Reveals Recurrent Mutations in Components of Ubiquitin-Dependent Pathways","volume":"108","author":"Wu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"eaav4772","DOI":"10.1126\/scitranslmed.aav4772","article-title":"A Multimodality Test to Guide the Management of Patients with a Pancreatic Cyst","volume":"11","author":"Springer","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/PPO.0b013e31827459b6","article-title":"Pathology and Molecular Genetics of Pancreatic Neoplasms","volume":"18","author":"Wood","year":"2012","journal-title":"Cancer J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/j.gastro.2015.07.041","article-title":"A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts","volume":"149","author":"Springer","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI84424","article-title":"Targeting Noncoding RNAs in Disease","volume":"127","author":"Adams","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4251\/wjgo.v8.i1.18","article-title":"MicroRNA in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions","volume":"8","author":"Hernandez","year":"2016","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/annonc\/mds513","article-title":"The Good, the Bad and the Ugly: A Tale of MiR-101, MiR-21 and MiR-155 in Pancreatic Intraductal Papillary Mucinous Neoplasms","volume":"24","author":"Caponi","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4161\/cbt.8.4.7338","article-title":"MicroRNA MiR-155 Is a Biomarker of Early Pancreatic Neoplasia","volume":"8","author":"Habbe","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1245\/s10434-014-3946-5","article-title":"Epithelial-to-Mesenchymal Transition (EMT) in Intraductal Papillary Mucinous Neoplasm (IPMN) Is Associated with High Tumor Grade and Adverse Outcomes","volume":"21","author":"Lahat","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Permuth-Wey, J., Chen, Y.A., Fisher, K., McCarthy, S., Qu, X., Lloyd, M.C., Kasprzak, A., Fournier, M., Williams, V.L., and Ghia, K.M. (2015). A Genome-Wide Investigation of MicroRNA Expression Identifies Biologically-Meaningful MicroRNAs That Distinguish between High-Risk and Low-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116869"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"15911","DOI":"10.1002\/jcp.28248","article-title":"LncRNA TUSC7 Suppresses Pancreatic Carcinoma Progression by Modulating MiR-371a-5p Expression","volume":"234","author":"Yue","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"15619","DOI":"10.1002\/jcp.28209","article-title":"LINC00052 Functions as a Tumor Suppressor through Negatively Modulating MiR-330-3p in Pancreatic Cancer","volume":"234","author":"Xiong","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1002\/cam4.2927","article-title":"Identification of Key LncRNAs in the Tumorigenesis of Intraductal Pancreatic Mucinous Neoplasm by Coexpression Network Analysis","volume":"9","author":"Ding","year":"2020","journal-title":"Cancer Med."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"He, X., Fan, R., Sun, J., Ren, Y., Zhao, X., Rui, W., Yuan, Y., and Zou, D. (2023). A Model for Predicting Degree of Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1087852"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/SLA.0000000000002015","article-title":"Development and Validation of a Multi-Institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium","volume":"267","author":"Attiyeh","year":"2018","journal-title":"Ann. Surg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/SLA.0000000000002421","article-title":"Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"268","author":"Attiyeh","year":"2018","journal-title":"Ann. Surg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"031507","DOI":"10.1117\/1.JMI.7.3.031507","article-title":"Multimodal Radiomics and Cyst Fluid Inflammatory Markers Model to Predict Preoperative Risk in Intraductal Papillary Mucinous Neoplasms","volume":"7","author":"Harrington","year":"2020","journal-title":"J. Med. Imaging"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of International Consensus Fukuoka Guidelines for the Management of IPMN of the Pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"European Study Group on Cystic Tumours of the Pancreas (2018). European Evidence-Based Guidelines on Pancreatic Cystic Neoplasms. Gut, 67, 789\u2013804.","DOI":"10.1136\/gutjnl-2018-316027"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4240\/wjgs.v2.i10.347","article-title":"Extent of Surgical Resections for Intraductal Papillary Mucinous Neoplasms","volume":"2","author":"Crippa","year":"2010","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e25535","DOI":"10.1016\/j.heliyon.2024.e25535","article-title":"Radiomics Advances in the Evaluation of Pancreatic Cystic Neoplasms","volume":"10","author":"Mao","year":"2024","journal-title":"Heliyon"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1002\/mp.13159","article-title":"CT Radiomics to Predict High-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"45","author":"Chakraborty","year":"2018","journal-title":"Med. Phys."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrgastro.2010.193","article-title":"Controversies in the Management of Pancreatic IPMN","volume":"8","author":"Tanaka","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.gastro.2015.01.015","article-title":"Clinical Guidelines Committee; American Gastroenterology Association American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts","volume":"148","author":"Vege","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pan.2012.04.004","article-title":"International Consensus Guidelines 2012 for the Management of IPMN and MCN of the Pancreas","volume":"12","author":"Tanaka","year":"2012","journal-title":"Pancreatology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jamasurg.2023.7010","article-title":"Optimal Surveillance Interval of Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"159","author":"Han","year":"2024","journal-title":"JAMA Surg."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.suc.2019.12.006","article-title":"Robotic Pancreatic Surgery for Solid, Cystic, and Mixed Lesions","volume":"100","author":"Rosemurgy","year":"2020","journal-title":"Surg. Clin. N. Am."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1007\/s00464-017-5523-z","article-title":"Total Robotic Pancreaticoduodenectomy: A Systematic Review of the Literature","volume":"31","author":"Kornaropoulos","year":"2017","journal-title":"Surg. Endosc."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.gassur.2004.03.005","article-title":"Pancreaticoduodenectomy","volume":"8","author":"Warshaw","year":"2004","journal-title":"J. Gastrointest. Surg."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/13651820500468059","article-title":"Distal Pancreatic Resection: Technical Differences between Open and Laparoscopic Approaches","volume":"8","year":"2006","journal-title":"HPB"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic Cancer: A Review of Clinical Diagnosis, Epidemiology, Treatment and Outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_112","first-page":"239","article-title":"The \u201cNouvelle Vague\u201d of Surgeons in Pancreatic Surgery: Can They Rise to the Legacy of Current Surgeons?","volume":"22","author":"Papalampros","year":"2017","journal-title":"J. BUON"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jamcollsurg.2015.09.007","article-title":"Balance Between Technical Novelty and Clinical Fidelity Is the Cornerstone in Pancreatic Surgery","volume":"222","author":"Papalampros","year":"2016","journal-title":"J. Am. Coll. Surg."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jviscsurg.2016.05.004","article-title":"A Safe and Feasible \u201cClock-Face\u201d Duct-to-Mucosa Pancreaticojejunostomy with a Very Low Incidence of Anastomotic Failure: A Single Center Experience of 248 Patients","volume":"153","author":"Papalampros","year":"2016","journal-title":"J. Visc. Surg."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00000658-199709000-00004","article-title":"Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990s","volume":"226","author":"Yeo","year":"1997","journal-title":"Ann. Surg."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00000658-199905000-00012","article-title":"Distal Pancreatectomy: Indications and Outcomes in 235 Patients","volume":"229","author":"Lillemoe","year":"1999","journal-title":"Ann. Surg."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.hpb.2018.05.001","article-title":"The Role of Central Pancreatectomy in Pancreatic Surgery: A Systematic Review and Meta-Analysis","volume":"20","author":"Xiao","year":"2018","journal-title":"HPB"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.dld.2018.11.028","article-title":"Risk of Advanced Lesions in Patients with Branch-Duct IPMN and Relative Indications for Surgery According to European Evidence-Based Guidelines","volume":"51","author":"Borbath","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.surg.2016.09.026","article-title":"Enucleation: A Treatment Alternative for Branch Duct Intraductal Papillary Mucinous Neoplasms","volume":"161","author":"Kaiser","year":"2017","journal-title":"Surgery"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.21873\/anticanres.11324","article-title":"Technical Feasibility and Oncological Legitimacy of Enucleation of Intraductal Papillary Mucinous Neoplasm Located at the Pancreatic Head or Uncinate Process","volume":"37","author":"Soejima","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.hpb.2019.04.015","article-title":"Enucleation for Branch Duct Intraductal Papillary Mucinous Neoplasms: A Systematic Review and Meta-Analysis","volume":"21","author":"Ratnayake","year":"2019","journal-title":"HPB"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.hbpd.2019.09.004","article-title":"Safety of Endoscopic Ultrasound-Guided Ethanol Ablation for Pancreatic Cystic Lesions: A Single-Center Experience of 214 Patients","volume":"18","author":"Choi","year":"2019","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1053\/j.gastro.2017.08.009","article-title":"The Safety and Efficacy of an Alcohol-Free Pancreatic Cyst Ablation Protocol","volume":"153","author":"Moyer","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/s-0043-110030","article-title":"Long-Term Outcomes after Endoscopic Ultrasound-Guided Ablation of Pancreatic Cysts","volume":"49","author":"Choi","year":"2017","journal-title":"Endoscopy"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MEG.0000000000001297","article-title":"The Efficacy and Safety of Endoscopic Ultrasound-Guided Ablation of Pancreatic Cysts with Alcohol and Paclitaxel: A Systematic Review","volume":"31","author":"Attila","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11894-019-0686-5","article-title":"EUS-Guided Pancreatic Cyst Ablation: A Clinical and Technical Review","volume":"21","author":"Moyer","year":"2019","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"E1064","DOI":"10.1055\/a-0959-5870","article-title":"Position Statement on EUS-Guided Ablation of Pancreatic Cystic Neoplasms from an International Expert Panel","volume":"7","author":"Teoh","year":"2019","journal-title":"Endosc. Int. Open"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1001\/jamasurg.2021.0950","article-title":"Risk of the Watch-and-Wait Concept in Surgical Treatment of Intraductal Papillary Mucinous Neoplasm","volume":"156","author":"Tjaden","year":"2021","journal-title":"JAMA Surg."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/SLA.0b013e318155a9e5","article-title":"Intraductal Papillary Mucinous Neoplasms","volume":"246","author":"Schmidt","year":"2007","journal-title":"Ann. Surg."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.soc.2015.11.006","article-title":"Therapeutic Approach to Cystic Neoplasms of the Pancreas","volume":"25","author":"Allen","year":"2016","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jamcollsurg.2006.12.040","article-title":"Fate of the Remnant Pancreas after Resection of Noninvasive Intraductal Papillary Mucinous Neoplasm","volume":"204","author":"White","year":"2007","journal-title":"J. Am. Coll. Surg."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000445019","article-title":"Is It Time to Expand the Role of Total Pancreatectomy for IPMN?","volume":"33","author":"Griffin","year":"2016","journal-title":"Dig. Surg."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.ejso.2016.06.402","article-title":"Selecting Optimal Surgical Procedures for Intraductal Papillary Mucinous Neoplasm (IPMN): An Analysis Based on the Surveillance, Epidemiology, and End Result Registry Database","volume":"42","author":"Wang","year":"2016","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/SLA.0000000000001319","article-title":"Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-Associated Carcinomas (\u226420-Mm Invasive Component)","volume":"263","author":"Winter","year":"2016","journal-title":"Ann. Surg."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1245\/s10434-018-6445-2","article-title":"Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN)","volume":"25","author":"Attiyeh","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1477-2574.2011.00354.x","article-title":"Outcome of the Pancreatic Remnant Following Segmental Pancreatectomy for Non-Invasive Intraductal Papillary Mucinous Neoplasm","volume":"13","author":"Miller","year":"2011","journal-title":"HPB"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.pan.2023.02.008","article-title":"Surveillance after Resection of Non-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN). A systematic review","volume":"23","author":"Miyasaka","year":"2023","journal-title":"Pancreatology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00535-019-01617-2","article-title":"Recurrence Patterns after Surgical Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas; a Multicenter, Retrospective Study of 1074 IPMN Patients by the Japan Pancreas Society","volume":"55","author":"Hirono","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/SLA.0000000000001817","article-title":"Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas","volume":"266","author":"Pea","year":"2017","journal-title":"Ann. Surg."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/SLA.0000000000000470","article-title":"Long-Term Prospective Cohort Study of Patients Undergoing Pancreatectomy for Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"260","author":"Kang","year":"2014","journal-title":"Ann. Surg."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1097\/SLA.0000000000004478","article-title":"Fate of Patients With Intraductal Papillary Mucinous Neoplasms of Pancreas After Resection According to the Pathology and Margin Status","volume":"276","author":"Kim","year":"2022","journal-title":"Ann. Surg."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pan.2020.03.009","article-title":"Impact of Adjuvant Therapy in Patients with Invasive Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"20","author":"Rodrigues","year":"2020","journal-title":"Pancreatology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cncr.29803","article-title":"The Efficacy of Adjuvant Therapy for Pancreatic Invasive Intraductal Papillary Mucinous Neoplasm (IPMN)","volume":"122","author":"McMillan","year":"2016","journal-title":"Cancer"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1245\/s10434-011-2088-2","article-title":"Adjuvant Radiotherapy in the Treatment of Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas: An Analysis of the Surveillance, Epidemiology, and End Results Registry","volume":"19","author":"Worni","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.ejso.2022.01.028","article-title":"Determining the Role of Adjuvant Therapy in Invasive Intraductal Papillary Mucinous Neoplasms; a Systematic Review and Meta-Analysis","volume":"48","author":"Hughes","year":"2022","journal-title":"Eur. J. Surg. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/22\/3825\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:32:15Z","timestamp":1760113935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/22\/3825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":145,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["cancers16223825"],"URL":"https:\/\/doi.org\/10.3390\/cancers16223825","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}